GSK has escalated a dispute over rights to its cancer immunotherapy Jemperli, after its subsidiary Tesaro filed a complaint ...

The direct-to-employer (DTE) is an industry first for FDA-approved weight-loss drugs like Novo Nordisk's Wegovy (semaglutide) ...

A recent scientific preprint published by Paradromics reported that the Connexus implant – a tiny device that is implanted ...

Patients in England and Wales with cardiomyopathy caused by the disorder ATTR amyloidosis will soon be able to access ...

Merck KGaA has teamed up with Flagship Pioneering's Valo Health on an ambitious project to apply AI to the discovery of novel ...

Indeed, creating a ‘smart investment strategy’ offers wide-ranging benefits – healthcare providers can innovate, patients ...

Leela Barham highlights data that shows that indication-specific pricing has been used in England for at least four years and ...

Bayer has billed Lynkuet as its next major pharma launch, saying it is due to start rolling out in the US later this month, ...

By moving early, Novo Nordisk has got in with its price cut ahead of Lilly, whose deal involved dual GLP-1/CIP agonist ...

China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could ...

BMS and J&J's Librexia AF study is also comparing milvexian to Eliquis to see if it can prevent stroke and other clotting ...

Roche's oral selective oestrogen receptor degrader (SERD) giredestrant has achieved what the company says is a stellar result ...